NCT06339801View on ClinicalTrials.gov

Role of Mucosal Impedance Measurement for the Diagnosis of Gastroesophageal Reflux Disease

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

August 1, 2026

Conditions
Gastroesophageal Reflux
Interventions
DEVICE

MiVu

All patients will undergo mucosal impedance (MI) measurement using the MiVu™ Mucosal Integrity Testing System (Diversatek Healthcare, Inc.).

Trial Locations (1)

1119

RECRUITING

Hospital de Clinicas, Buenos Aires

All Listed Sponsors
lead

Hospital de Clinicas José de San Martín

OTHER